Home › Stocks › TRDA

Entrada Therapeutics, Inc. (TRDA): insider buying, hedge funds & Congress trades

Entrada Therapeutics, Inc. (TRDA): 3 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Nov 24, 2025Baker Felix
TenPercentOwner
28,867$9.07$261.8Kno history
Nov 12, 2025Baker Bros. Advisors (GP) LLC
TenPercentOwner
178,044$7.60$1.4Mno history
Jun 18, 2025Kim Peter S
Director
50,000$14.63$731.8Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for TRDA

Free account. Know when insiders, famous funds or Congress trade it.

Start free